TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Pelago Bioscience AB
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 7,440 | 7,220 | 6,256 |
Financial expenses | 5 | 2 | 4 |
Earnings before taxes | 515 | 979 | 948 |
EBITDA | 979 | 1,372 | 1,276 |
Total assets | 6,441 | 5,936 | 4,488 |
Current assets | 5,098 | 4,134 | 3,656 |
Current liabilities | 3,406 | 3,129 | 2,508 |
Equity capital | 2,810 | 2,590 | 1,855 |
- share capital | 5 | 5 | 5 |
Employees (average) | 51 | 39 | 27 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 43.6% | 43.6% | 41.3% |
Turnover per employee | 146 | 185 | 232 |
Profit as a percentage of turnover | 6.9% | 13.6% | 15.2% |
Return on assets (ROA) | 8.1% | 16.5% | 21.2% |
Current ratio | 149.7% | 132.1% | 145.8% |
Return on equity (ROE) | 18.3% | 37.8% | 51.1% |
Change turnover | 804 | 1,079 | 1,965 |
Change turnover % | 12% | 18% | 46% |
Chg. No. of employees | 12 | 12 | 5 |
Chg. No. of employees % | 31% | 44% | 23% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.